A provider of a semiconductor chip platform for neural devices and brain-computer interfaces
mintneuro.comLinkedInLondon, UKSemiconductorsFounded 2022
25 sources
The source describes this as an investment round but does not state a series or other stage. It names “early investors” without identifying them.
2 sources
The release does not state a round stage, financing total, valuation, or headquarters. It also mentions several prominent angel investors without naming them.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Seed | $5M | ~ 2026-10-05 | Odyssey | No recent discussion |
25 sources [ VERIFIED ] read against 1 of 25 sources The source describes this as an investment round but does not state a series or other stage. It names “early investors” without identifying them. | ||||
MintNeuro builds purpose-built, low-power semiconductor chips for medical-device companies and researchers to put inside neural devices for sensing, stimulation and signal processing.
Neural implants can be bulky, power-intensive and dependent on invasive surgery, while neurological disorders affect more than one billion people globally; MintNeuro's chips aim to make these devices smaller, lower-power, scalable and less invasive. The October 2026 $5 million round matters because the company says it now has working silicon, integration milestones with Motif Neurotech and Amber Therapeutics, and a multi-year commercial supply agreement with Motif, giving it capital to launch products and support wider adoption.
Checked against 10 sources on Oct 7
| Funding round [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $1.3M £1 million | 2024-11-12 | Empirical Ventures | No recent discussion |
2 sources [ VERIFIED ] read against 1 of 2 sources The release does not state a round stage, financing total, valuation, or headquarters. It also mentions several prominent angel investors without naming them. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]2 pages read: prnewswire.com, imperial.ac.uk·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]confirmedchecked against 1 of 2 sources·[ BRANDING ]logo and colour from the homepage·[ AGENT ]company research by the Firecrawl agent | ||||
Also named as backers in company research: Imperial College Enterprise Fund, Advanced Research and Invention Agency (ARIA), Innovate UK, National Institute for Health and Care Research (NIHR)